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Abstract
Objective—To develop a model using individual and lesion characteristics to help surgeons choose
lesions with a high probability of containing histologically-confirmed endometriosis.
Design—Secondary analysis of prospectively collected information. Setting: Government research
hospital.
Patients—Healthy women aged 18–45 with chronic pelvic pain and possible endometriosis,
enrolled in a clinical trial.
Intervention—All participants underwent laparoscopy, and information was collected on all visible
lesions. Lesion data were randomly allocated to a training and test dataset.
Main Outcome Measures(s)—Predictive logistic regression with the outcome of interest being
histologic diagnosis of endometriosis.
Results—After validation, the model was applied to the complete dataset with a sensitivity of 88.4%
and specificity of 24.6%. The positive predictive value was 69.2% and the negative predictive value
was 53.3%, equating to correct classification of a lesion of 66.5%. Mixed color, larger width and
location in the ovarian fossa, colon, or appendix were most strongly associated with the presence of
endometriosis.
Conclusions—This model identified characteristics which indicated a high and low probability of
biopsy-proven endometriosis. It is useful as a guide in choosing appropriate lesions for biopsy, but
is not sufficiently robust to use alone.
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According to the 2005 ESHRE guidelines (1), the 2000 ACOG Practice Bulletin(2), and the
2005 ACOG Committee Opinion (3), in some circumstances it is acceptable to diagnose
endometriosis based on the visual appearance of lesions at laparoscopy. In questionable cases,
biopsy with histologic confirmation of the disease is recommended, but positive histology is
not a requisite for diagnosis in all cases. The responsibility of identifying endometriosis rests
with the surgeon, who must recognize endometriosis using only visual assessment at surgery
(4).
Unfortunately, visual assessment of lesions has poor intra-physician agreement and high rates
of misdiagnosis (5) and correlates poorly with actual histologic findings (4,6–14). Presurgical
screening tests to increase the probability of a woman having endometriosis at surgery are one
way to improve the likelihood of accurate diagnosis. However, questionnaires, MRI, ultrasound
and adjunctive lab tests all lack the sensitivity and specificity to significantly increase the pre-
test probability of disease (1,8,11,15,16), except for women with severe endometriosis (Stage
III or IV) (6,17–19). Based on these facts, some method to assess which lesions are most likely
to represent true disease is needed, particularly if visual appearance is used.
At surgery, endometriosis lesions present with a variety of colors, sizes, and locations (8,10,
11,15,20). The heterogeneity of lesion characteristics suggests that visual inspection may not
be sufficient to identify endometriosis (9), especially when subtle lesions are present. Thus
development of a model synthesizing multiple factors might improve the accuracy of diagnosis
or at least guide the surgeon regarding which lesions are most likely to be positive on biopsy.
By correlating patient and individual lesion characteristics with pathologic findings in a
multivariate regression model, we sought to assess which lesions are most likely to be biopsy-
confirmed as endometriosis. Knowing this fact might improve on the poor histologic
correlation with surgical assessment (4,6–14).
Methods
This is a secondary data analysis of a clinical study which received IRB approval from both
the NIH and University of North Carolina-Chapel Hill. Data were collected from 119 women
aged 18–45 who were enrolled in a clinical trial for the treatment of chronic pelvic pain and
endometriosis, from 1999 to 2004, that combined laparoscopic excision of all lesions with
medical treatment. Women were healthy with the exception of pelvic pain lasting at least three
months.
Data Collection
After providing informed consent, all participants underwent laparoscopy. At surgery,
information was collected on all visible lesions as previously described (11). Lesions suspected
of being endometriosis were excised with contact neodymium:yttrium-aluminum-garnet laser
(Surgical Laser Technologies, The Oaks, PA); no lesions were ablated and all were sent for
histology. When cysts were present, the walls were stripped from the surrounding tissue. An
appendectomy was performed if there was chronic inflammation or endometriosis involving
this structure. Peritoneal defects were excised in-toto whenever possible. To minimize
unreasonable risks to the patient, deep implants were not resected if found in the recto-vaginal
septum or transmural to the bowel wall.
The following categories were used to identify the location of the lesion: bladder/peritoneum,
colon/appendix, cul-de-sac, ovarian fossa, ovary, sidewall, utero-sacral ligament, and the
uterus/fallopian tube. Each lesion was measured across two diameters, and averaged. If lesions
were closely spaced (within 0.5 cm of each other) the measurement included the distance across
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all lesions. Color categories included red, white, black, mixed, and endometriomas, and the
type of lesions as judged by the surgeon (endometriotic vs. nonendometriotic) was also
recorded. Finally, the revised American Fertility Society (revASRM) classification system was
used to estimate the severity or stage of the disease in the pelvis (21).
Histology was only considered to be positive if both endometrial glands and stroma were
identified.
All lesions identified as endometriosis by the surgeon were eligible for inclusion in the model.
To remain in the dataset, the observation for each lesion had to have complete covariate data
of lesion characteristics, as well as histology results, revASRM disease stage, and patient
demographics.
Data Analysis
For the model development, data were randomly allocated to one of two datasets (designated
the training and test dataset) using Stata Version 8.2 (Stata Corporation, College Station, TX).
The model was developed in the training dataset and validated in the test dataset. Univariate
analysis was done for each variable to assess distribution and the need for transformation.
The model was developed using logistic regression with the histologic diagnosis of
endometriosis as the outcome of interest. Variance estimates for individual parameters were
adjusted for multiple observations taken from single participants and the non-independence of
these observations. Lesion color, location, stage, and race were treated as categorical variables.
Age, BMI, and lesion width were evaluated for linearity in the logit before being included as
continuous variables. Transformations were not required for these variables. Categorical
variables were condensed based on similarities of the estimates in the model and tests of
heterogeneity across categories. Therefore, categories were constructed based on
mathematical, not clinical criteria.
The Hosmer-Lemeshow goodness-of-fit test was used to test the predictive ability (calibration)
of the model. The area under the receiver-operator characteristic (ROC) curve evaluated the
discrimination of the model fit. Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV), as well as percent of lesions correctly classified were
calculated for the combined data. Analyses were done using Stata Version 8.2 (College Station,
TX).
Results
There were a total of 530 observations from 119 women that were potentially eligible for
inclusion in the model. Forty-three observations (8.1% of the complete dataset) were dropped
during modeling because of missing covariate information. A total of 114 women contributing
complete data on 487 lesions, of which 320 (65.7%) had histologically confirmed
endometriosis. Approximately 2/3 of the observations (n = 334) were included in the training
dataset and the remainder (n = 153) were included in the test dataset. Since each lesion was
considered separately during the allocation process, the same woman could contribute lesions
to both datasets. Thus, 104 women contributed to the training dataset, and 77 women to the
validation dataset.
Of women in the complete dataset, 92 reported their race as white (80.7%). Forty (35%) had
stage I disease, 46 (40%) had stage II disease, 17 (6%) had stage III disease, and 11 (9%) had
stage IV disease. The mean age of the study participants was 31.4 ± 7.2 years (range 18–45)
and the mean BMI was 25 ± 4.7 (range 17.2–44.5). Forty percent of lesions were located in
the cul-de-sac or utero-sacral ligaments. The majority of the lesions were subtle lesions (red
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or white, 51.6%)(Table 1). The distributions of age, race, BMI, stage, lesion location, color,
width and histologically confirmed endometriosis did not differ significantly between the
training and validation datasets, suggesting that participant characteristics were reasonably
well-balanced.
The Hosmer-Lemeshow goodness-of-fit test for the training dataset was used to validate the
model. The p value was estimated at 0.78, indicating good calibration of the model to the
dataset. The test dataset had a p value of 0.30, again showing good calibration. The area under
the ROC curve for the training dataset was 0.70 indicating only fair discrimination of the model
which was similar to the test dataset at 0.69.
After validating the model, it was applied to the complete dataset to determine characteristics
predictive of endometriosis. Lesions located on the ovarian fossa, colon, or appendix were 25%
more likely than those on the uterus, ovary, fallopian tubes, cul-de-sac, or utero-sacral
ligaments to contain histologically-confirmed endometriosis (Table 1). The odds that a given
lesion was confirmed to be endometriosis increased by 5% per millimeter of lesion width
(OR=1.05, 95% CI 1.02, 1.09). Lesions from women classified as having Stage I disease were
significantly less likely to contain endometriosis than women with Stage II-IV disease
(OR=0.49, 95% CI 0.31, 0.79). The odds of lesions of mixed color truly containing
endometriosis were 87% greater than those that were red or white (OR=1.87; 95% CI 1.05,
3.34), yet, red or white lesions were as likely as those that were blue, black, brown, or
endometriomas to be confirmed as endometriosis. Age and BMI were not associated with
changes in the odds of histologically-confirmed endometriosis.
The model was also used to explore the change in the probability of confirming endometriosis
by adjusting each variable in relation to the referent (most common) value for each
characteristic. The largest change in percentage occurred among different locations (from
−22% to +3%), and the smallest change was observed with age (from −2% to +2%). Using the
characteristics with the highest probability of confirming endometriosis, a nearly 3 cm wide,
mixed color lesion in the ovarian fossa from a 42 year old Caucasian woman with a BMI of
15 and at least stage II disease had the highest probability of endometriosis (92.9%; 95% CI:
0.73, 0.98). By contrast, a small red lesion on the bladder peritoneum from a 22 year old non-
Caucasian woman with stage I endometriosis had the lowest probability of confirmed
endometriosis (22.0%; CI: 0.09, 0.45).
We also determined the sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV) of the final model. The model predicted the presence of endometriosis
with a sensitivity of 88.8% and predicted the absence of endometriosis with a specificity of
24.6%. The PPV was 69.3% and the NPV 53.3%. This equated to correct classification of a
lesion of 66.5% (Figure 1).
Discussion
Overall, this model had a modest ability to predict endometriosis from individual lesion
characteristics. We found moderate associations between the characteristics of size, location
and mixed color with endometriosis, but, as expected, no other single lesion characteristic
predicted endometriosis with a high accuracy. Lesions of any single color had similar
probabilities of being confirmed as endometriosis. A mixed color lesion increased the
probability of confirming endometriosis from 66% to 78%.
Lesion size and location were more helpful in predicting biopsy-positive endometriosis lesions.
This model confirmed that wider lesions had a greater probability of containing endometriosis,
with an increase of 17% noted in comparing a 2.7mm to a 27.7mm lesion. Likewise, there was
a 17% increase in the probability of confirming biopsy-proven endometriosis in identical
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lesions located in the ovarian fossa compared to the uterus. However, while endometriosis was
commonly found in the cul-de-sac or on the utero-sacral ligaments, location alone did not
correlate well with the presence of endometriosis on biopsy.
This model provides guidance about appropriate lesions to biopsy for confirmation of the
disease. Information about subtle lesions may be useful to direct the surgeon to biopsy atypical,
low probability lesions to ensure that endometriosis is the true diagnosis. For instance, a large
lesion in the ovarian fossa that is of mixed color has a 93% probability of being endometriosis
and may not need to be biopsied unless definitive diagnosis is needed, such as would be required
for entry into a study protocol. However, a small red or white lesion on the uterus has just a
22% chance of containing endometriosis, and if other high probability lesions were not seen,
a biopsy of this lesion would be appropriate to confirm the presence of the disease.
Overall, basing the diagnosis of endometriosis on subtle lesions alone is problematic because
of the variable appearance of these lesions. (4,10–13). Martin et al (4) reported a 30% increase
in the diagnosis of endometriosis in women overall when biopsies were taken from all abnormal
appearing tissue (subtle findings), and not just from tissue suspected to be endometriosis. Until
another method of easily identifying endometriosis in these lesions at surgery is found, our
results indicate it is prudent to confirm the diagnosis of endometriosis by biopsy in women
with atypical lesions.
Our model aptly described results in the study group, but may not be generalizable to the
population at large or to women with infertility, but not pain. All subjects had symptoms
consistent with pain associated with endometriosis; therefore the findings at laparoscopy may
be most relevant for lesions likely to cause pain but not with infertility. Had we sampled women
with pain-free endometriosis or those with infertility, we might have found different
associations. However, random laparoscopies in asymptomatic women present ethical issues
and women with endometriosis related infertility undergoing in vitro fertilization may not
undergo laparoscopy. Also, the clinical trial was not designed to define lesion characteristics,
and normal peritoneum was not routinely sampled as a control. This may account for the low
specificity and low negative predictive value since lesions believed to be negative were not
routinely sampled.
In conclusion, our findings are consistent with previously published reports that use of a lesion
color is a poor predictor for the presence of endometriosis and that endometriosis is found in
lesions of any single colors with similar frequencies. Width, location, mixed color, and race
were modestly predictive of endometriosis, whereas stage of disease was more strongly
predictive. Overall, our model increased the sensitivity of identifying endometriosis in
individual lesions from 65.7% to 88%, but had a poor specificity, meaning that we could not
reliably predict lesions that did not contain endometriosis. This model was able to identify
lesions with a high (93%) or low (22%) probability of containing endometriosis, but also
demonstrated the need for disease confirmation by biopsy in women with subtle lesions. The
information we present provides useful guidelines to aid in decision making about the
likelihood of a patient having endometriosis at the time of surgery and to help differentiate
between high and low probability lesions for biopsy if this diagnosis is in question, thus
supporting excising rather than ablating any high probability lesion. This model augments, but
does not replace, clinical judgment.
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ROC curve. Model correctly predicts endometriosis in 66.7% of the time. Area under ROC
curve=0.7026
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Table 1
Distribution of lesion characteristics, odds ratios for association of lesion
characteristics with histologically-confirmed endometriosis, and calculated
probability of histologically-confirmed endometriosis of each characteristic
(derived from the model after adjustment of all other variables).








 Bladder/peritoneum, round/broad, sidewall 129 (26.5) 0.42 (0.25, 0.71) 0.44 (0.15, .078) −22
 Uterus, ovary, fallopian tube 106 (21.8) 0.50 (0.26, 0.97) 0.49 (0.18, 0.81) −17
 Cul-de-sac, utero-sacrals ligaments (referent) 196 (40.3) ------ 0.66 (0.30, 0.89) ------
 Ovarian fossa, colon, appendix 56 (11.5) 1.18 (0.70, 1.98) 0.69 (0.34, 0.91) 3
Color Groupsb
 Red or white 251 (51.6) --- 0.66 (0.30, 0.89) ---
 Blue, black, brown, endometrioma 136 (27.9) 1.21 (0.76, 1.93) 0.69 (0.33, 0.91) 3
 Mixed colors 100 (20.5) 1.87 (1.05, 3.34) 0.78 (0.44, 0.94) 12
Racec
 Nonwhite 82 (16.8) 0.67 (0.40, 1.12) 0.56 (0.22, 0.85) 10
 White (referent) 405 (83.2) --- 0.66 (0.30, 0.89) ---
Staged
 I 99 (20.3) 0.49 (0.31, 0.79) 0.48 ( 0.17, 0.81) −18
 II, III, IV 388 (79.7) --- 0.66 (0.30, 0.89) ---
Median (range) OR per unit
increase (95%CI)
Width of lesion (mm)d 5 (1–90) 1.05 (1.02, 1.09)
 2.7 0.59 (0.25, 0.87) −7
 7.7 (mean, referent) 0.66 (0.30, 0.89) ---
 12.7 0.71 (0.35, 0.92) 4
 17.7 0.76 (0.40, 0.94) 8
 22.7 080 (0.45, 0.95) 10
BMI (kg/m2)e 24.3 (17.2-4.5) 0.97 (0.93, 1.01)
 35 0.59 (0.19, 0.90) −4
 30 0.62 (0.24, 0.90) −2
 25 (mean, referent) 0.66 (0.30, 0.89) ---
 20 0.68 (0.36, 0.89) 2
 15 0.71 (0.43, 0.89) 4
Age (yrs)f 31 (17–46) 1.01 (0.98, 1.04)
 21.4 0.63 (0.32, 0.87) −2
 26.4 0.64 (0.31, 0.88) 0
 31.4 (mean, referent) 0.66 (0.30, 0.89) ---
 36.4 0.66 (0.29, 0.91) 1
 41.4 0.67 (0.28, 0.92) 2
a
For each calculation using location, color group=red or white (reference level), race=white (reference level), width=7.7, stage=II, III, IV (reference level),
BMI=25 (reference level), Age=31.4 (reference level)
b
For each calculation using color group, location= Cul-de-sac, utero-sacrals ligaments (referent), race=white (reference level), width=7.7, stage=II, III,
IV (reference level), BMI=25 (reference level), Age=31.4 (reference level)
c
For each calculation using race, location= Cul-de-sac, utero-sacrals ligaments (referent), color group=red or white (reference level), width=7.7, stage=II,
III, IV (reference level), BMI=25 (reference level), Age=31.4 (reference level)
d
For each calculation using width, location= Cul-de-sac, utero-sacrals ligaments (referent), color group=red or white (reference level), race=white
(reference level, stage=II, III, IV (reference level), BMI=25 (reference level), Age=31.4 (reference level)
e
For each calculation using stage, location= Cul-de-sac, utero-sacrals ligaments (referent), color group=red or white (reference level), race=white
(reference level), width=7.7, BMI=25 (reference level), Age=31.4 (reference level)
f
For each calculation using Age, location= Cul-de-sac, utero-sacrals ligaments (referent), color group=red or white (reference level), race=white (reference
level), width=7.7, stage=II, III, IV (reference level), BMI=25 (reference level)
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